Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 145 (1999), 809-818; DOI  10.1099/13500872-145-4-809
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaur, R.
Right arrow Articles by Bachhawat, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaur, R.
Right arrow Articles by Bachhawat, A. K.
Agricola
Right arrow Articles by Kaur, R.
Right arrow Articles by Bachhawat, A. K.

The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae

Rupinder Kaur and Anand K. Bachhawat

Institute of Microbial Technology, Sector 39-A, Chandigarh — 160 036, India

Author for correspondence: Anand K. Bachhawat. Tel: +91 172 690004/690908. Fax: +91 172 690585/690632. e-mail: abachhawat@excite.com

ABSTRACT

Summary: Mutants of Saccharomyces cerevisiae bearing lesions in the ergosterol biosynthetic pathway exhibit a pleiotropic drug-sensitive phenotype. This has been reported to result from an increased permeability of the membranes of the mutant strains to different drugs. As disruption of the yeast multidrug resistance protein, Pdr5p, results in a similar pleiotropic drug-sensitive phenotype, the possibility that Pdr5p may be functioning with a reduced efficiency in these altered sterol backgrounds was examined. To do this, the function of Pdr5p in isogenic strains of S. cerevisiae that have disruptions in the late stages of the ergosterol biosynthesis pathway (ERG6, ERG2, ERG3, ERG4) was studied. A reduced ability of Pdr5p to confer resistance to different drugs in these strains was observed, which did not appear to be dependent solely on the permeability of the membrane towards the drug. A simultaneous examination was made of how the lipid composition might be altering the efficiency of Pdr5p by similar studies in strains lacking phosphatidylserine synthase (encoded by CHO1). The results indicated that the drug sensitivity of the erg strains is, to a significant extent, a result of the reduced efficiency of the Pdr5p efflux pump, and that the membrane environment plays an important role in determining the drug resistance conferred by Pdr5p.


Keywords: Saccharomyces cerevisiae, multidrug resistance pump, membrane environment, sterols, erg mutants




This article has been cited by other articles:


Home page
MicrobiologyHome page
T. Iwaki, H. Iefuji, Y. Hiraga, A. Hosomi, T. Morita, Y. Giga-Hama, and K. Takegawa
Multiple functions of ergosterol in the fission yeast Schizosaccharomyces pombe
Microbiology, March 1, 2008; 154(3): 830 - 841.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
K. Gulshan and W. S. Moye-Rowley
Multidrug Resistance in Fungi
Eukaryot. Cell, November 1, 2007; 6(11): 1933 - 1942.
[Full Text] [PDF]


Home page
Eukaryot CellHome page
J. B. Anderson, N. Ricker, and C. Sirjusingh
Antagonism between Two Mechanisms of Antifungal Drug Resistance.
Eukaryot. Cell, August 1, 2006; 5(8): 1243 - 1251.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
L. Walsh, P.W. Hastwell, P.O. Keenan, A.W. Knight, N. Billinton, and R.M. Walmsley
Genetic modification and variations in solvent increase the sensitivity of the yeast RAD54-GFP genotoxicity assay
Mutagenesis, September 1, 2005; 20(5): 317 - 327.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. Pasrija, S. Krishnamurthy, T. Prasad, J. F. Ernst, and R. Prasad
Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans
J. Antimicrob. Chemother., June 1, 2005; 55(6): 905 - 913.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
C. V. Srikanth, A. K. Chakraborti, and A. K. Bachhawat
Acetaminophen toxicity and resistance in the yeast Saccharomyces cerevisiae
Microbiology, January 1, 2005; 151(1): 99 - 111.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
S. Krishnamurthy, A. Plaine, J. Albert, T. Prasad, R. Prasad, and J. F. Ernst
Dosage-dependent functions of fatty acid desaturase Ole1p in growth and morphogenesis of Candida albicans
Microbiology, June 1, 2004; 150(6): 1991 - 2003.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Pinjon, G. P. Moran, C. J. Jackson, S. L. Kelly, D. Sanglard, D. C. Coleman, and D. J. Sullivan
Molecular Mechanisms of Itraconazole Resistance in Candida dubliniensis
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2424 - 2437.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
K. Umebayashi and A. Nakano
Ergosterol is required for targeting of tryptophan permease to the yeast plasma membrane
J. Cell Biol., June 23, 2003; 161(6): 1117 - 1131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-i. Hayashi, A. M. Jones, K. Ogino, A. Yamazoe, Y. Oono, M. Inoguchi, H. Kondo, and H. Nozaki
Yokonolide B, a Novel Inhibitor of Auxin Action, Blocks Degradation of AUX/IAA Factors
J. Biol. Chem., June 20, 2003; 278(26): 23797 - 23806.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. D. Rogers and K. S. Barker
Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates
Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1220 - 1227.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Mukhopadhyay, A. Kohli, and R. Prasad
Drug Susceptibilities of Yeast Cells Are Affected by Membrane Lipid Composition
Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3695 - 3705.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. D. Rogers and K. S. Barker
Evaluation of Differential Gene Expression in Fluconazole-Susceptible and -Resistant Isolates of Candida albicans by cDNA Microarray Analysis
Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3412 - 3417.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Kohli, N. Smriti, K. Mukhopadhyay, A. Rattan, and R. Prasad
In Vitro Low-Level Resistance to Azoles in Candida albicans Is Associated with Changes in Membrane Lipid Fluidity and Asymmetry
Antimicrob. Agents Chemother., April 1, 2002; 46(4): 1046 - 1052.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. Fleming, E. S. Lightcap, S. Sadis, V. Thoroddsen, C. E. Bulawa, and R. K. Blackman
Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341
PNAS, February 5, 2002; 99(3): 1461 - 1466.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
S. Tugendreich, E. Perkins, J. Couto, P. Barthmaier, D. Sun, S. Tang, S. Tulac, A. Nguyen, E. Yeh, A. Mays, et al.
A Streamlined Process to Phenotypically Profile Heterologous cDNAs in Parallel Using Yeast Cell-Based Assays
Genome Res., November 1, 2001; 11(11): 1899 - 1912.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
D. P. Kontoyiannis
Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae
J. Antimicrob. Chemother., August 1, 2000; 46(2): 199 - 203.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1999 Society for General Microbiology.